Japan’s MHLW Approves Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay as the CDx for Daiichi Sankyo’s Quizartinib for Treatment of Relapsed/Refractory FLT3-ITD AML. Expands Use to Include Specimens Collected in EDTA

2019-07-04T21:08:52+00:00June 19th, 2019|Categories: Press Releases|Tags: , , , , , , , |

⟵  PRESS RELEASES PRESS RELEASE SAN DIEGO, [...]